PharmaShots | Incisive News in 3 Shots

Subscribe Now

kidney disease

Boehringer Ingelheim and Eli Lilly's Jardiance (empagliflozin) Receives the US FDA's Fast Track Designation for Chronic Kidney Disease

Boehringer Ingelheim and Eli Lilly's Jardiance (empagliflozin) Receives the US FDA's Fast Track Designation for Chronic Kidney Dis...

March 13, 2020

AstraZeneca Reports Results of Roxadustat in Global Phase III Programme for Cardiovascular Safety in Patients with Chronic Kidney Disease

AstraZeneca Reports Results of Roxadustat in Global Phase III Programme for Cardiovascular Safety in Patients with Chronic Kidney...

May 10, 2019

Akebia Therapeutics Reports Positive Results of Vadadustat in P-III J01 & J03 Studies for Anemia Due to Chronic Kidney Disease (CKD) in Japan

Akebia Therapeutics Reports Positive Results of Vadadustat in P-III J01 & J03 Studies for Anemia Due to Chronic Kidney Disease...

March 13, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us